Recommended by the CDC
The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends Prevnar 20 as an option for your eligible adult patients.2
|
Meet Prevnar 20 patient types
Patient profiles to help you determine which of your adult patients are eligible to receive Prevnar 20.
|
Built on an established vaccine
Prevnar 20 was built on the efficacy of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).1,3
|
Recommended by the CDC The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends Prevnar 20 as an option for your eligible adult patients.2 |
Meet Prevnar 20 patient types Patient profiles to help you determine which of your adult patients are eligible to receive Prevnar 20. |
Built on an established vaccine Prevnar 20 was built on the efficacy of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).1,3 |
Patients should always ask their healthcare providers for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967.
Please click for Prevnar 20™ Full Prescribing Information.
Please click for Prevnar 13® Full Prescribing Information.
Prevnar 13® Limitations of Use: Prevnar 13® will only help protect against S. pneumoniae serotypes in the vaccine
Prevnar 13® Limitations of Use: Prevnar 13® will only help protect against S. pneumoniae serotypes in the vaccine